N(ε)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress

Atherosclerosis

Volumn 144, Issue 1, 1999, Pages 41-47

  Nerlich, Andreas G ^a   Schleicher, Erwin D ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Viszeral und Transplantationschirurgie Tübingen   (Germany)

Author keywords

Biomarker; Glycoxidation; Lipid peroxidation; Macrophages; Unsaturated fatty acids

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; GLYCOSYLATED PROTEIN; LYSINE DERIVATIVE; N (CARBOXYMETHYL)LYSINE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; ADVANCED GLYCATION END PRODUCT; DRUG DERIVATIVE; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FETUS; HUMAN; HUMAN TISSUE; INTIMA; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; TUNICA MEDIA; AORTA; ARTERIOSCLEROSIS; CHEMISTRY; COMPARATIVE STUDY; CULTURE TECHNIQUE; IMMUNOHISTOCHEMISTRY; INFANT; METABOLISM; MIDDLE AGED; NEWBORN; PATHOLOGY; PREGNANCY; PRESCHOOL CHILD; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VASCULAR SMOOTH MUSCLE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AORTA; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CULTURE TECHNIQUES; FEMALE; FETUS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LIPID PEROXIDATION; LYSINE; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; PREGNANCY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0032588929     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00038-6     Document Type: Article

References (25)

1. Crawford D.W., Blankenhorn D.H. Arterial wall oxygenation, oxyradicals and atherosclerosis. Atherosclerosis. 89:1991;97-108.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
3. Offermann H.K., Medford R.M. Antioxidants and atherosclerosis: a molecular perspective. Heart Dis. Stroke. 3:1994;52-57.
4. Baynes J.W. Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
5. Knecht K.J., Dunn J.A., McFarland K.F., McCance D.R., Lyons T.J., Thorpe S.R., Baynes J.W. Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes. 40:1991;190-196.
6. ε-(carboxymethyl)lysine and (carboxymethyl) hydroxyllysine in human skin collagen. Biochemistry. 30:1991;1205-1210.
7. Dyer D.G., Dunn J.A., Thorpe S.R., Bailie K.E., Lyons T.J., McCance D.R., Baynes J.W. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91:1993;2463-2469.
8. ε-(carboxymethyl)lysine in lens protein. Biochemistry. 28:1989;9464-9468.
9. ε-(carboxymethyl) lysine as a degradation product of fructose lysine in glycated protein. J. Biol. Chem. 261:1986;4889-4894.
10. ε-(1-deoxy-D-fructos-1-yl)hippuryl-lysine. Eur. J. Biochem. 210:1992;729-739.
11. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271:1996;9982-9986.
12. ε-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99:1997;457-468.
13. Gempel K., Wagner E., Schleicher E. Characterization of antibodies against carboxymethyllysine-modified proteins. Labuza T.P., Reineccius G.A., Monnier V.M., O'Brien J., Baynes J.W. Maillard Reactions in Chemistry, Food and Health. 1994;392-396 The Royal Society of Chemistry, Cambridge, MA.
14. Nerlich A., Schleicher E. Immunohistochemical localization of extracellular matrix in human diabetic glomerular lesions. Am. J. Pathol. 139:1991;889-899.
15. Vogt B., Schleicher E., Wieland O.H. Amino-lysine-bound glucose in human tissues obtained at autopsy: increase in diabetes mellitus. Diabetes. 31:1982;1123-1127.
16. Schleicher E., Wieland O.H. Kinetic analysis of glycation as a tool for assessing the half-life of proteins. Biochim. Biophys. Acta. 884:1986;199-205.
17. Nerlich A. Collagen gene expression in postangioplasty stenosis. Circulation. 92:1995;2760-2761.
18. Palinsky W, Koschinsky T., Butler S.W., Miller E., Vlassra H., Cerami A., Witztum J.L. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscl. Thromb. Vasc. Biol. 15:1995;571-582.
19. Ledl F., Schleicher E. New aspects of the Maillard reaction in foods and in the human body. Angew Chem. Int. Ed. Engl. 6:1990;565-594.
20. Bucala R., Cerami A. Advanced glycosylation: chemistry, biology and implicatios for diabetes in aging. Adv. Pharmacol. 23:1992;1-34.
21. ε-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry. 35:1996;8075-8083.
22. ε-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) in tissue proteins. Biochemistry. 34:1995;10872-10878.
23. Nakamura Y., Horii Y., Nishino T., Shiiki H., Sakaguchi Y., Kagoshima T., Dohi K., Makita Z., Vlassara H., Bucala R. Immunohistochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus. Am. J. Pathol. 143:1993;1649-1656.
24. Kume S., Takeya M., Mori T., Araki N., Suzuki H., Horiuchi S., Kodama T., Miyauchi Y., Takahashi K. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 147:1995;654-667.
25. Vlassara H., Brownlee M., Cerami A. High-affintiy-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal if senescent macromolecules. Proc. Natl. Acad. Sci. USA. 82:1985;5588-5592.